References
Berlin M, Fogdell A, Olerup O, Eklund A, Grunewald J (1997) HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 156:1601–1605
Giscombe R, Grunewald J, Nityanand S, Lefvert AK (1995) TCR V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol 101:213–219
Grunewald J, Andersson R, Rydberg L, Gigliotti D, Schaufelberger C, Hansson G, Wigzell H (1994) CD4+ and CD8+ T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis Rheum 37:1221–1227
Grunewald J, Berlin Öhrn M, Olerup O, Persson U, Wigzell H, Eklund A (1994) T cell receptor (TCR) V gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid (BAL) and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 91:4965–4969
Grunewald J, Hultman T, Bucht A, Eklund A, Wigzell H (1995) Restricted usage of Vα/Jα gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients. Mol Med 1:287–296
Grunewald J, Halapi E, Wahlström J, Giscombe R, Nityanand S, Sanjievi C, Lefvert A-K (1998) T cell expansions with conserved T cell receptor β chain motifs in the peripheral blood of HLA-DRB 1 *0401 positive patients with necrotising vasculitis. Blood 92:3737–3744
Rights and permissions
About this article
Cite this article
Grunewald, J., Wigzell, H. Introduction. Springer Semin Immunopathol 21, 1–4 (1999). https://doi.org/10.1007/BF00815174
Issue Date:
DOI: https://doi.org/10.1007/BF00815174